drugset / Trial / NCT00908362

Impact of Fluticasone and Salmeterol on Airway Dendritic Cells (DCs) in Smokers

NCT00908362

Phase 1 Completed 45 enrolled University of Rostock GlaxoSmithKline · collab
RandomizedParallel-groupDouble-blindBasic science

Summary

Airway dendritic cells (DCs) play a key role in smoke-related lung diseases. In this study, the researchers investigate the effects of fluticasone and salmeterol on human airway DCs in smokers. The researchers hypothesize that fluticasone and salmeterol impact on the number and the characteristics of airway DCs in smokers.

Timeline

Start
2009-05
Primary completion
2009-10
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Fluticasone Other / unclassified 250 ug Inhaled
Comparator Salmeterol Other / unclassified 50 ug Inhaled